1. Home
  2. PBHC vs ONCY Comparison

PBHC vs ONCY Comparison

Compare PBHC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$16.15

Market Cap

99.9M

Sector

Finance

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

N/A

Current Price

$0.82

Market Cap

107.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBHC
ONCY
Founded
1859
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.9M
107.3M
IPO Year
2014
2002

Fundamental Metrics

Financial Performance
Metric
PBHC
ONCY
Price
$16.15
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
18.0K
1.5M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
2.94%
N/A
EPS Growth
46.25
N/A
EPS
0.47
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
$33.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$0.77
52 Week High
$17.40
$1.51

Technical Indicators

Market Signals
Indicator
PBHC
ONCY
Relative Strength Index (RSI) 51.50 40.45
Support Level $15.05 N/A
Resistance Level $17.11 $1.06
Average True Range (ATR) 0.69 0.07
MACD -0.10 -0.01
Stochastic Oscillator 33.26 3.49

Price Performance

Historical Comparison
PBHC
ONCY

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: